Angiogenesis [Cancer Research] — a collection of compounds that inhibit or modulate the formation of new blood vessels (angiogenesis), used as cancer research reagents, including kinase inhibitors such as sunitinib and regorafenib, thalidomide derivatives, and other small compounds that affect the VEGF signaling pathway and related growth factors.
The Angiogenesis category is used by oncology researchers to study the signaling pathways that regulate tumor blood vessel growth, ranging from receptor tyrosine kinase inhibition assays (for example VEGFR, PDGFR) to screening of anticancer compounds in cell and tissue models. Such reagents are also used in studies of the mechanism of action of candidate compounds and in the development of in vitro models to understand the interaction between tumors and their vascular environment.
Product examples in this collection: TCI U0095 341031-54-7 Sunitinib Malate, TCI G0458 6902-77-8 Genipin, TCI T3980 19388-87-5 Taurolidine, TCI G0546 184475-35-2 Gefitinib, TCI T2524 50-35-1 (+/-)-Thalidomide, TCI H1780 54952-43-1 (+/-)-Shikonin, TCI A3649 7753-60-8 Anecortave Acetate, TCI K0060 1225451-84-2 SKLB1002.
Pay attention to the analytical purity level, physical form (solid, salt, or ester), and storage stability of the compound when selecting items in this category, especially for specific stereoisomers that affect biological activity in research assays. All products are genuine Tokyo Chemical Industry (TCI) Japan products, with purity, packaging, and storage conditions listed on each item's page.
Other related categories under Cancer Research, often used together in one laboratory workflow:
Back to Cancer Research. For large-volume procurement, special packaging, or specific grades, contact the AMI Scientific team — the official TCI Japan distributor in Indonesia — to check availability and lead time directly from Japan.
